We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.
- Authors
Jin, Bo; Zhang, Yingmei; Hou, Wenyi; Cao, Fenglin; Lu, Ming; Yang, Huiyuan; Tian, Xuanyu; Wang, Yuan; Hou, Jinxiao; Fu, Jinyue; Li, Haitao; Zhou, Jin
- Abstract
Purpose: Early death (ED) is the main cause of acute promyelocytic leukemia (APL) treatment failure, and the ED rate is higher for elderly patients than that for young ones. To date, no studies have been found focusing on ED in elderly patients with APL. Methods: This study retrospectively analyzed the clinical data of 409 consecutive patients with APL (139 patients ≥ 50 years old, 270 patients < 50 years old). All patients received arsenic trioxide alone as induction therapy. The baseline clinical characteristics and ED occurrence and predictors between elderly and young patients with APL were compared and analyzed. Results: The clinical features of elderly patients at admission were not significantly different from those of young ones. The ED rate of elderly patients was significantly greater than that of young patients (23.74% vs 11.85%, P = 0.0018). Hemorrhage is the main cause of ED in elderly patients, followed by infection and differentiation syndrome. From the 15th to 30th days of treatment, elderly patients had a higher mortality rate than that of young patients (7.83% vs 2.06%, P = 0.009). Male, white blood cell (WBC) count > 10 × 109/L, fibrinogen < 1.0 g/L and low albumin levels were independent risk factors for ED in elderly patients, while ED was only correlated with WBC count, fibrinogen and creatinine levels in young patients. Conclusion: The results of this study may help design more rational treatment plans for elderly patients with APL based on early mortality risk to reduce the ED rate.
- Subjects
ACUTE promyelocytic leukemia; OLDER patients; EARLY death; ARSENIC trioxide; LEUCOCYTES; COMPARATIVE studies
- Publication
Journal of Cancer Research & Clinical Oncology, 2020, Vol 146, Issue 2, p485
- ISSN
0171-5216
- Publication type
Article
- DOI
10.1007/s00432-019-03076-x